Duncan S H, Leitch E C, Stanley K N, et al. Effects of esculin and esculetin on the survival of Escherichia coli O157 in human faecal slurries, continuous-flow simulations of the rumen and colon and in calves[J]. BrJ Nutr, 2004, 91(5) :749.
Tubaro A, Del Negro P, Ragazzi E, et al. Anti-inflammatory and peripheral analgesic activity of esculetin in vivo [J]. Pharmacol Res Commun, 1988,20 ( Suppl 5 ) :83.
[8]
Yamada H, Watanabe K, Saito T, et al. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA- 926, suppresses cartilage destruction in rabbit experimental osteoarthritis[J].J Rheumatol, 1999,26(3) :654.
Kuo P L, Huang Y T, Chang C H, et al. Fraxetin inhibits the induction of anti-Fas IgM, tumor necrosis factor-alpha and interleukin-lbeta-mediated apoptosis by Fas pathway inhibition in human osteoblastic cell line MG-63 [J]. Int Immunopharmacol, 2006,6(7) :1167.
[11]
Kuo P L, Huang Y T, Chang C H, et al. Bone morphogenetic protein-2 and -4 (BMP-2 and-4) mediates fraxetin-induced maturation and differentiation in human osteoblast-like cell lines [J]. Biol Pharm Bull, 2006,29(1) :119.
[12]
Stefanova Z, Neychev H, Ivanovska N, et al. Effect of a total extract from Fraxinus ornus stem bark and esculin on zymosan-and carrageenan-induced paw oedema in mice [J]. J Ethnopharmacol, 1995,46(2) :101.
[13]
段慧琴 张永东 范开 等.七叶亭抗炎机理研究[J].中国兽医杂志,2007,43(9):45.
[14]
Kawaii S, Tomono Y, Ogawa K, et al. The antiproliferative effect of coumarins on several cancer cell lines [J]. Anticancer Res, 2001,21 (2A) :917.
Wang C J, Hsieh Y J, Chu C Y, et al. Inhibition of cell cycle progression in human leukemia HL-60 cells by esculin [J]. Cancer Letters, 2002,183 : 163.
[17]
Chu C Y, Tsai Y Y, Wang C J, et al. Induction of apoptosis by esculetin in human leukemia cells[J]. Eur J Pharmacol, 2001, 416(1/2) :25.
[18]
Kuo H C, Lee H J, Hu C C, et al. Enhancement of esculetin on Taxol-induced apoptosis in human hepatoma HepG2 cells [J]. Toxicol Appl Pharmacol, 2006,210 ( 1/2 ) :55.
[19]
Leung K N, Leung P Y, Kong L P, et al. Immunomodulatory effects of esculetin (6, 7-dihydroxycoumarin) on murine lympho- cytes and peritoneal macrophages [J]. Cell Mol Immunol, 2005, 2(3) :181.
[20]
Kaneko T, Tahara S, Takabayashi F. Inhibitory effect of natural coumarin compounds, esculetin and esculin, on oxidative DNA damage and formation of aberrant crypt foci and tumors induced by 1, 2-dimethylhydrazine in rat colons [J]. Biol Pharm Bull, 2007,30( 11 ) :2052.
[21]
Lin H C, Tsai S H, Chen C S, et al. Structure-activity relationship of coumarin derivatives on xanthine oxidase-inhibiting and free radical-scavenging activities [J]. Biochem Pharmacol, 2008,75(6) :1416.
[22]
Lee B C, Lee S Y, Lee H J, et al. Anti-oxidative and photo-protective effects of coumarins isolated from Fraxinus chinensis [J]. Arch Pharm Res, 2007,30(10) :1293.
[23]
Kaneko T, Tahara S, Takabayashi F. Suppression of lipid hy-droperoxide-induced oxidative damage to cellular DNA by esculetin[J]. Biol Phann Bull, 2003,26(6) :840.
[24]
Martin-Aragon S, Benedf J M, Villar A M. Effects of the antioxidant (6, 7-dihydroxycoumarin) esculetin on the glutathione system and lipid peroxidation in mice [J]. Gerontology, 1998,44 (1) :21.
[25]
Martin-Aragon S, Benedi J M, Villar A M. Modifications on antioxidant capacity and lipid peroxidation in mice under fraxetin treatment[J]. J Pharm Phannacol, 1997,49(1 ) :49.
[26]
梁敏.秦皮抗氧化成分的分离及其活性研究[J].食品工业科技,2006,(3):64-66.
[27]
Wie M B, Koh J Y, Won M H, et al. BAPTA/AM, an intracellular calcium chelator, induces delayed necrosis by lipoxygenasemediated free radicals in mouse cortical cultures[J]. Neuropharmacology, 2001,25 (8) : 1641.
[28]
Zhao D L, Zou L B, Lin S, et al. Anti-apoptotic effect of esculin on dopamine-induced cytotoxicity in the human neuroblastoma SH-SY5 Y cell line [J]. Neurophannacology, 2007,53 ( 6 ) : 724.
[29]
Zhao D L, Zou L B, Lin S, et al. 6, 7-di-O-glucopyranosyl-esculetin protects SH-SY5Y cells from dopamine-induced cytotoxicity[J]. Eur J Pharmacol, 2008,580(3 ) :329.
[30]
Sanchez-Reus M I, Peinado I I, Molina-Jimenez M F, et al. Fraxetin prevents rotenone-induced apoptosis by induction of endogenous glutathione in human neuroblastoma cells[J]. Neurosci Res, 2005,53( 1 ) :48.
[31]
Molina-Jimanez M F, S6nchez-Reus M I, Cascales M, et al. Effect of fraxetin on antioxidant defense and stress proteins in human neuroblastoma cell model of rotenone neurotoxicity. Comparative study with myricetin and N-acetylcysteine[J]. Toxicol Appl Pharmacol, 2005,209 ( 3 ) :214.
[32]
Molina-Jimenez M F, Sanchez-Reus M I, Andres D, et al. Neuroprotective effect of fraxetin and myricetin against rotenone-induced apoptosis in neuroblastoma cells [J]. Brain Res, 2004, 1009(1/2) :9.
[33]
Molina-Jimenez M F, S6nchez-Reus M I, Benedi J. Effect of fraxetin and myricetin on rotenone-induced cytotoxicity in SH- SYSY cells : comparison with N-acetylcysteine [J]. Eur J Pharmacol, 2003,472(1/2) :81.
Pan S L, Huang Y W, Guh J H, et al. Esculetin inhibits Rasmediated cell proliferation and attenuates vascular restenosis following angioplasty in rats [J]. Biochem Pharmacol, 2003,65 (11) :1897.
[36]
Lee M J, Chou F P, Tseng T H, et al. Hibiscus protocatechuic acid or esculetin can inhibit oxidative LDL induced by either copper ion or nitric oxide donor[J]. J Agric Food Chem, 2002,50 (7) :2130.
[37]
Kong L, Zhou J, Wen Y, et al. Aesculin possesses potent hypouricemic action in rodents but is devoid of xanthine oxidase/de-hydrogenase inhibitory activity[J]. Planta Med, 2002,68 (2) : 175.
Gilani A H, Janbaz K H, Shah B H. Eseuletin prevents liver damage induced by paracetamol and CC14 [J]. Pharmacol Res, 1998,37( 1 ) :31.
[40]
Lin W L, Wang C J, Tsai Y Y, et al. Inhibitory effect of esculetin on oxidative damage induced by t-butyl hydroperoxide in rat liver[J]. Arch Toxicol, 2000,74(8) :467.
Klein-Galczinsky C. Pharmacological and clinical effectiveness of a fixed phytogenic combination trembling poplar (Populus tremula), true goldenrod ( Solidago virgaurea) and ash ( Fraxinus excelsior) in mild to moderate rheumatic complaints [J]. Wien Med Wochenschr, 1999,149 (8/10) :248.
